Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,560 signal articles · 37 in last 24h · 122,487 total before filter · latest 36m ago
37last 24h
1247last 7d
205● bullish (7d)
149● bearish (7d)
205publishers
AllMacro210Earnings420M&A98Regulatory24Product8Analyst10
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off
StockStory61d agobullish
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Southern Copper (SCCO) Beats 2026 Output Goal And Plans $20.5 Billion Expansion
Simply Wall St.61d agobullish
Southern Copper (SCCO) Beats 2026 Output Goal And Plans $20.5 Billion Expansion

Southern Copper (NYSE:SCCO) reports that it has surpassed its copper production targets for 2026. The company outlines plans to invest over US$20.5b over the next decade to expand output in Peru and Mexico. Management highlights ongoing operational challenges, including lower ore grades and recent production declines. Southern Copper links its long-term investment program to expected demand tied to AI infrastructure and electrification trends. Southern Copper is one of the largest...

Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy
Simply Wall St.61d agobullish
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy

Hims & Hers Health (NYSE:HIMS) is expanding its GLP-1 weight-loss treatment offerings, adding new options to its telehealth platform. The company has entered into a partnership with Novo Nordisk to provide access to medications such as Wegovy and Ozempic. Hims & Hers Health is extending its international reach through the acquisition of Eucalyptus. Hims & Hers Health, best known for its direct-to-consumer telehealth services, is moving deeper into prescription weight management at a time...

3 Market-Beating Stocks to Target This Week
StockStory61d agobullish
3 Market-Beating Stocks to Target This Week

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

Chevron Corporation (CVX): Top 10 Cheap Jim Cramer Stocks To Buy
Insider Monkey61d agobullish
Chevron Corporation (CVX): Top 10 Cheap Jim Cramer Stocks To Buy

Chevron Corporation (NYSE:CVX) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. On May 21, 2026, Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE:CVX), launched its next-generation Techron fuel additive across all grades at Chevron and Texaco stations nationwide. The scientifically tested reformulation is designed to protect engines from […]